Vector delivery technique affects gene transfer in the cornea in vivo
Rajiv R Mohan1, Ajay Sharma, Tyler C Cebulko
1Mason Eye Institute, School of Medicine, Department of Ophthalmology, College of Veterinary Medicine, University of Missouri, and Ophthalmology Research, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65212, USA. mohanr@health.missouri.edu
Molecular Vision
|December 9, 2010
Summary
Controlled corneal drying significantly enhances vector absorption in the eye. This minimally invasive technique shows promise for targeted gene therapy delivery with minimal side effects.
Area of Science:
- Ophthalmology
- Gene Therapy
- Biomaterials Science
Background:
- Gene therapy holds promise for treating ocular diseases.
- Efficient delivery of therapeutic vectors to the cornea is crucial for successful gene therapy.
- Current delivery methods often involve invasive procedures with potential side effects.
Purpose of the Study:
- To investigate if controlled corneal drying enhances vector absorption in mouse, rabbit, and human corneas.
- To evaluate the effects of corneal drying on gene transfer, corneal structure, and inflammatory responses in vivo.
Main Methods:
- Corneal epithelium was removed, followed by controlled drying using a hair dryer for varying durations.
- Balanced salt solution (BSS) absorption was quantified.
- Adeno-associated virus 8 (AAV8) vector was applied to study gene transfer, with analysis of gene expression, morphology, and inflammation.
Main Results:
- Corneal drying significantly increased BSS absorption in a time-dependent manner.
- 50 seconds of drying led to higher transgene delivery in mouse corneas but with mild-to-moderate morphological changes.
- 30 seconds of drying achieved significant gene transfer without compromising corneal morphology, with minimal inflammatory cell infiltration.
Conclusions:
- Controlled corneal drying is an effective method to increase vector absorption.
- Optimized topical application of AAV serotypes following controlled drying can achieve high, targeted gene expression in the cornea.
- This minimally invasive approach offers a promising strategy for ocular gene therapy with reduced side effects.


